Bg pattern

MALAWAY 250 MG/100 MG FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MALAWAY 250 MG/100 MG FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Malaway 250 mg/100 mg film-coated tablets EFG

Atovaquone/Proguanil Hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
    1. If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
    • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Malaway is and what it is used for
  2. What you need to know before you take Malaway
  3. How to take Malaway
  4. Possible side effects
  5. Storing Malaway
  6. Contents of the pack and other information

1. What Malaway is and what it is used for

Malaway belongs to a group of medicines called antimalarials. It contains two active substances, atovaquone and proguanil hydrochloride.

Malaway has two uses:

  • Prevention of malaria in adults and children weighing over 40 kg
  • Treatment of malaria in adults and children weighing over 11 kg

Malaria is spread by the bite of an infected mosquito, which injects the malaria parasite (Plasmodium falciparum) into the blood. Malaway prevents malaria by killing this parasite. For people who have already been infected with malaria, Malaway also kills these parasites.

Protect yourself from getting malaria

Anyone, of any age, can get malaria. It is a serious disease, but it is preventable. Even when taking Malaway, it is very important that you take precautions to avoid being bitten by mosquitoes.

  • Use mosquito repellent on all exposed areas of the body.
  • Wear light-colored clothing that covers as much of the body as possible,especially in the evening when mosquitoes are most active.
  • Sleep in a room protectedagainst mosquitoes or under a mosquito net impregnated with insecticide.
  • Close windows and doors at sunset,if they are not protected.
  • Consider using an insecticide(tablet, spray, electric mosquito killer) to clear the room of insects or prevent them from entering the room.

If you need more advice,consult your doctor or pharmacist.

Even when taking all necessary precautions, it is still possible to get malaria.Some types of malaria infection can take a long time to cause symptoms; therefore, the disease may not start until several days, weeks, or even months after returning from travel.

Consult a doctor immediately if you have symptomssuch as fever, headache, chills, or fatigue after returning from abroad.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Malaway

Do not take Malaway

  • If you are allergic to atovaquone and/or proguanil or any of the other ingredients of this medicine (listed in section 6).
  • For the prevention of malaria, if you have severe kidney problems.

Warnings and precautions

Consult your doctor or pharmacist before starting to take this medicine.

For the prevention of malaria:

  • If you feel unwell (vomit) during the first hour after taking Malaway tablets, take another dose quickly.
  • It is essential to take all of the Malaway medicine. If you need to take an additional dose due to vomiting, you may need another prescription.
  • If you have been vomiting, it is especially important to use additional protection, such as repellents and mosquito nets. Malaway may not be as effective, as the amount absorbed will be lower.

For the treatment of malaria:

  • If you have been vomiting and have diarrhea, consult your doctor. You will need regular blood tests. As the amount of Malaway absorbed is reduced, it may not be as effective. The tests will check if the malaria parasite is being eliminated from your blood.
  • If you have severe kidney disease, your doctor may want to prescribe a different medicine.
  • If you contract any infection while being treated with Malaway, your doctor may prescribe a different type of medicine instead of Malaway.
  • If malaria is treated, but you still get it again, or if the malaria is caused by a certain type of parasite, your doctor may prescribe another medicine in addition to Malaway.

Other medicines and Malaway

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Some medicines may affect how Malaway works, or Malaway may enhance or reduce the effect of other medicines used at the same time. These include:

  • Metoclopramide, used to treat nausea and vomiting.
  • Antibiotics: tetracycline, rifampicin, rifabutin.
  • Efavirenz or some protease inhibitors used to treat HIV.
  • Indinavir, used to treat HIV.
  • Warfarin and other anticoagulant medicines.
  • Etoposide used to treat cancer.

Tell your doctor if you are taking any of these. Your doctor may decide that Malaway is not suitable for you, or that you need to have additional checks while taking it.

Rememberto consult your doctor if you start taking any other medicine while taking Malaway.

Taking Malaway with food and drinks

Take Malaway with food or a dairy drink, if possible. This will increase the amount of Malaway that your body can absorb, and make your treatment more effective.

It is preferable not to split the tablets.

Pregnancy and breastfeeding

If you are pregnant, breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Do not take Malaway unless your doctor advises you to.

Do not breastfeed while taking Malaway, as the components of Malaway may pass into breast milk and harm your baby.

Driving and using machines

If you feel dizzy, do not drive. Malaway can make some people feel dizzy. If this happens to you, do not drive, use machines, or take part in activities that may put you or others at risk.

3. How to take Malaway

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

Take Malaway with food or a dairy drink whenever possible.

It is recommended to take Malaway every day at the same time.

Prevention of malaria:

The usual dose in adults and adolescents weighing over 40 kg is one tablet once a day, taken as indicated below.

In children, consult your doctor.

Malaway is not recommended for the prevention of malaria in children or in adults or adolescents weighing less than 40 kg.

In your country, a different type of Malaway tablet may be available for children.

For the prevention of malaria in adults:

  • Start taking Malaway 1 or 2 days before traveling to a malaria area.
  • Continue taking it daily during the trip and continue taking it for another 7 days after returning to a malaria-free area.

Take all the Malaway tablets for maximum protection.

Stopping it early means a risk of getting malaria, as 7 days are needed to ensure the death of the parasites that may be in your body from the bite of an infected mosquito.

Treatment of malaria:

The recommended dose in adults is 4 tablets once a day for 3 days.

For children weighing 11 kg or more:

  • 11 to 20 kg – 1 tablet per day for 3 days.
  • 21 to 30 kg – 2 tablets per day for 3 days.
  • 31 to 40 kg – 3 tablets per day for 3 days.
  • over 40 kg – the same dose as for adults.

Malaway is not recommended for the treatment of malaria in children weighing less than 11 kg.

For children weighing less than 11 kg, consult your doctor. There may be another type of Malaway tablet available for children in your country.

If you take more Malaway than you should

Contact your doctor or pharmacist for advice and, if possible, show them the medicine pack.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91.562.04.20, indicating the medicine and the amount ingested.

If you forget to take Malaway

It is very important that you take the complete treatment of Malaway. If you forget a dose, do not worry. Take the next dose as soon as you remember. Then continue the treatment as you were doing before. Do not take a double dose to make up for forgotten doses.

Do not stop treatment with Malawaywithout consulting your doctor

Continue taking Malawayfor 7 days after returning from a malaria-free area. Take the complete treatment of Malaway to achieve maximum protection. If you stop it early, you risk getting malaria, as 7 days are needed to ensure the death of the parasites that may be in your body from the bite of an infected mosquito.

Consult your doctor or pharmacist for advice on what to do.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Be aware of the following serious reactions. They have been seen in a small number of people, although their exact frequency is unknown.

Severe allergic reactions. The signs include:

  • Rash and itching.
  • Sudden wheezing, chest or throat tightness, or difficulty breathing.
  • Swelling of the eyelids, face, lips, tongue, or any other part of the body.

If you get any of these symptoms, contact a doctor immediately. Stop taking Malaway.

Severe skin reactions:

  • A skin rash that may have blisters and looks like targets (central dark spots surrounded by lighter areas with a dark ring around the edge) (erythema multiforme).
  • A severe widespread skin rash with blisters and peeling of the skin, especially around the mouth, nose, eyes, and genitals (Stevens-Johnson syndrome).

If you notice any of these symptoms, contact a doctor urgently.

Most other side effects reported have been mild and have not lasted long.

Very common side effects (may affect more than 1 in 10 people):

  • Headache
  • Feeling and being sick (nausea and vomiting)
  • Stomach pain
  • Diarrhea

Common side effects (may affect up to 1 in 10 people):

  • Dizziness
  • Sleeping problems (insomnia)
  • Unusual dreams
  • Depression
  • Lack of appetite
  • Fever
  • Skin rash
  • Cough
  • Allergic reactions
  • Itching (pruritus)

Common side effects that may be found in your blood tests:

  • Decrease in the number of red blood cells (anemia) that can cause tiredness, headache, and difficulty breathing.
  • Decrease in the number of white blood cells (neutropenia) that makes you more prone to infections.
  • Low sodium levels in the blood (hyponatremia).
  • Increased liver enzymes

Uncommon side effects (may affect up to 1 in 100 people)

These may affect up to 1 in 100 people:

  • Anxiety
  • An unusual awareness of an abnormal heartbeat (palpitations),
  • Swelling and redness of the mouth
  • Red, itchy lumps on the skin (urticaria)
  • Hair loss

Uncommon side effects that may be found in your blood tests:

  • Increased amylase (an enzyme produced in the pancreas)

Rare side effects: may affect up to 1 in 10,000 people

  • Seeing or hearing things that are not there (hallucinations)

Other side effects:Other side effects have occurred in a small number of people, although their frequency is unknown

  • Liver inflammation (hepatitis)
  • Bile duct obstruction (cholestasis)
  • Increased heart rate (tachycardia)
  • Blood vessel inflammation (vasculitis) that can be seen as red or purple spots, although it can affect other parts of the body
  • Seizures (convulsions)
  • Panic attacks, crying
  • Nightmares
  • Serious mental health problems, in which the person loses contact with reality and is unable to think and judge clearly
  • Mouth ulcers
  • Blisters
  • Peeling of the skin
  • Increased sensitivity of the skin to light
  • Stomach problems (gastric intolerance)

Other side effects that may be found in your blood tests:

  • A decrease in all types of blood cells (pancytopenia).

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Reporting of side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Malaway

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month shown.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Container Content and Additional Information

Composition of Malaway

  • The active ingredients are atovaquone and proguanil hydrochloride.

Each tablet contains 250 mg of atovaquone and 100 mg of proguanil hydrochloride.

  • The other components are:

Tablet core: poloxamer 188, microcrystalline cellulose, low-substituted hydroxypropylcellulose, povidone K30, sodium carboxymethyl starch (type A) (potato), colloidal anhydrous silica, magnesium stearate.

Film coating: hypromellose, titanium dioxide (E171), red iron oxide (E172), Macrogol 400, Macrogol 8000.

Appearance of the Product and Container Content

Malaway are pink-brown, round, biconvex tablets, with a beveled edge, film-coated, and marked on one side with "404" and with "G" on the other.

Malaway is presented in PVC/PVDC (transparent) blisters and rigid and tempered aluminum PVC/PVDC sheets.

Container sizes: 12, 24, 36, 60 tablets.

Only some container sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing authorization holder:

Glenmark Arzneimittel GmbH

Industriestr. 31

82194 Gröbenzell

Germany

Manufacturer:

Glenmark Pharmaceuticals s.r.o.

Fibíchova 143

566 17 Vysoké Mýto

Czech Republic

You can request more information about this medication by contacting the local representative of the marketing authorization holder:

Glenmark Farmacéutica, S.L.U.

C/ Retama 7, 7th floor

28045 Madrid

Spain

This medication is authorized in the member states of the European Economic Area under the following names:

Country

Medication Name

Germany

Atovaquon/Proguanilhydrochlorid Glenmark 250 mg /100 mg Filmtabletten

Austria

Atovaquon/Proguanilhydrochlorid Glenmark 250 mg/100 mg Filmtabletten

Denmark

Atovaquone/Proguanil Glenmark 250 mg /100 mg Filmovertrukne tabletter

Spain

Malaway 250 mg/100 mg film-coated tablets EFG

France

Atovaquone/Proguanil BGR 250 mg /100 mg comprimé pelliculé

Ireland

Atovaquone/Proguanil Hydrochloride 250 mg /100 mg Film-coated tablets

Norway

Atovaquone/Proguanil Glenmark

Netherlands

Atovaquone/Proguanilhydrochloride Glenmark 250 mg /100 mg Filmomhulde Tabletten

Poland

Falcimar

Sweden

Atovaquone/Proguanil Glenmark 250/100 mg filmdragerade tabletter

Date of the Last Revision of this Prospectus:December 2023.

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

Online doctors for MALAWAY 250 MG/100 MG FILM-COATED TABLETS

Discuss questions about MALAWAY 250 MG/100 MG FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for MALAWAY 250 MG/100 MG FILM-COATED TABLETS?
MALAWAY 250 MG/100 MG FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MALAWAY 250 MG/100 MG FILM-COATED TABLETS?
The active ingredient in MALAWAY 250 MG/100 MG FILM-COATED TABLETS is proguanil and atovaquone. This information helps identify medicines with the same composition but different brand names.
How much does MALAWAY 250 MG/100 MG FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for MALAWAY 250 MG/100 MG FILM-COATED TABLETS is around 19.84 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures MALAWAY 250 MG/100 MG FILM-COATED TABLETS?
MALAWAY 250 MG/100 MG FILM-COATED TABLETS is manufactured by Glenmark Arzneimittel Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MALAWAY 250 MG/100 MG FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MALAWAY 250 MG/100 MG FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MALAWAY 250 MG/100 MG FILM-COATED TABLETS?
Other medicines with the same active substance (proguanil and atovaquone) include ATOVACUONE/PROGUANIL HYDROCHLORIDE VIATRIS 250 mg/100 mg FILM-COATED TABLETS, MALARONE 250 mg/100 mg FILM-COATED TABLETS, MALARONE PEDIATRIC 62.5 mg/25 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media